logo BDSP

Base documentaire

  1. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease : a population-based case-control study.

    Article - En anglais

    Preliminary animal and human data suggest that estrogens may be protective against Alzheimer's disease in women.

    In a population-based case-control study at Group Health Cooperative of Puget Sound, Seattle, Washington, the authors compared the exposure of estrogen replacement therapy of 107 female Alzheimer's disease cases with 120 age-and sex-matched controls by using computerized pharmacy data.

    The cases were obtained from the Alzheimer's Disease Patient Registry of the University of Washington, Seattle, Washington, which is based on the enumerated health plan population from 1987 to 1992.

    Newly recognized cases of probable Alzheimer's disease according to standardized diagnostic criteria were ascertained, evaluated, and enrolled in the Registry.

    Mots-clés Pascal : Démence Alzheimer, Epidémiologie, Prévention, Oestrogène, Hormone stéroïde sexuelle, Chimiothérapie, Postménopause, Homme, Femelle, Washington, Etats Unis, Amérique du Nord, Amérique, Système nerveux pathologie, Système nerveux central pathologie, Encéphale pathologie, Maladie dégénérative

    Mots-clés Pascal anglais : Alzheimer disease, Epidemiology, Prevention, Estrogen, Sex steroid hormone, Chemotherapy, Postmenopause, Human, Female, Washington, United States, North America, America, Nervous system diseases, Central nervous system disease, Cerebral disorder, Degenerative disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 94-0624944

    Code Inist : 002B02O. Création : 09/06/1995.